Current Issue | Archives | Suppl.
Vol. 91 Suppl. : February 2008
|
The Need for Guidelines and the Use of Economic
Evidence in Decision-Making in Thailand:
Lessons Learnt from the Development of
the National List of Essential Drugs
View Abstract Download |
S1 |
|
Making Sensible Rationing: The Use of Economic Evidence
and the Need for Methodological Standards
View Abstract Download |
S4 |
|
Making Health Technology Assessment Information
Available for Decision Making: The Development
of a Thai Database
View Abstract Download |
S8 |
|
Thai Health Technology Assessment Guideline Development
View Abstract Download |
S11 |
|
Defining the Scope of Economic Evaluation Study and
Selection of Comparators
View Abstract Download |
S16 |
|
Defining Types of Economic Evaluation
View Abstract Download |
S21 |
|
Measurement of Costs
View Abstract Download |
S28 |
|
Measurement of Clinical Effects
View Abstract Download |
S38 |
|
Measurement of Clinical-Effect: Utility
View Abstract Download |
S43 |
|
Handling Time in Economic Evaluation Studies
View Abstract Download |
S53 |
|
Handling Uncertainty of the Economic Evaluation
Result: Sensitivity Analysis
View Abstract Download |
S59 |
|
Presentation of Economic Evaluation Results
View Abstract Download |
S66 |
|
Health System and Equity Perspectives in
Health Technology Assessment
View Abstract Download |
S74 |
|
Policy Making and Roles of Health Technology Assessment
View Abstract Download |
S88 |
|
A Determination of Topics for Health Technology
Assessment in Thailand: Making Decision
Makers Involved
View Abstract Download |
S100 |
|
Costs of Injuries Due to Interpersonal and Self-Directed
Violence in Thailand, 2005
View Abstract Download |
S110 |
|
Cost-Utility Analysis of Recombinant Human
Erythropoietin in Anemic Cancer Patients
Induced by Chemotherapy in Thailand
View Abstract Download |
S119 |
|
The Cost-Effectiveness Analysis of Initiating HIV/AIDS
Treatment with Efavirenz-Based Regimens Compared
with Nevirapine-Based Regimens in Thailand
View Abstract Download |
S126 |
